Molecules 2010, 15(11), 8144-8155; doi:10.3390/molecules15118144
Article

2-Chlorophenyl Zinc Bromide: A Convenient Nucleophile for the Mannich-Related Multicomponent Synthesis of Clopidogrel and Ticlopidine

1email, 1email, 1,* email, 1email and 2email
Received: 8 October 2010; in revised form: 2 November 2010 / Accepted: 9 November 2010 / Published: 11 November 2010
Download PDF [155 KB, uploaded 18 June 2014]
Abstract: A methodological study devoted to the Mannich-like multicomponent synthesis of the antiplatelet agent (±)‑clopidogrel (7) and the ethyl ester analogue 6 is described. The process involves the formation of 2-chlorophenyl zinc bromide (2) and its subsequent reaction with an alkyl glyoxylate and 4,5,6,7-tetrahydrothieno[3,2-c]pyridine (3). We demonstrate that the organozinc reagent 2 also constitutes a very convenient nucleophile for the multicomponent synthesis of the benzylamine core of ticlopidine (9).
Keywords: multicomponent reactions; organozinc reagents; amino acids; cobalt; zinc
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Aillaud, I.; Haurena, C.; Gall, E.L.; Martens, T.; Ricci, G. 2-Chlorophenyl Zinc Bromide: A Convenient Nucleophile for the Mannich-Related Multicomponent Synthesis of Clopidogrel and Ticlopidine. Molecules 2010, 15, 8144-8155.

AMA Style

Aillaud I, Haurena C, Gall EL, Martens T, Ricci G. 2-Chlorophenyl Zinc Bromide: A Convenient Nucleophile for the Mannich-Related Multicomponent Synthesis of Clopidogrel and Ticlopidine. Molecules. 2010; 15(11):8144-8155.

Chicago/Turabian Style

Aillaud, Isabelle; Haurena, Caroline; Gall, Erwan Le; Martens, Thierry; Ricci, Gino. 2010. "2-Chlorophenyl Zinc Bromide: A Convenient Nucleophile for the Mannich-Related Multicomponent Synthesis of Clopidogrel and Ticlopidine." Molecules 15, no. 11: 8144-8155.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert